Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-κB and the tat transactivator

Virology

Volumn 296, Issue 1, 2002, Pages 77-83

  Roof, Philippe ^a   Ricci, Maria ^a   Genin, Pierre ^a   Montano, Monty A ^b,c   Essex, Max ^b   Wainberg, Mark A ^a   Gatignol, Anne ^a   Hiscott, John ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Harvard AIDS Institute   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene transcription; HIV 1 LTR; NF B; Tat

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSACTIVATOR PROTEIN;

ACETYLATION; ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036343111     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1397     Document Type: Article

References (34)

1. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat
2. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants
3. Duration of nuclear NF-κB action regulation by reversible acetylation
4. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes
5. HIV-1 auxiliary proteins: Making connections in a dying cell
6. NF-kappaB activation and HIV-1 induced apoptosis
7. Difference in susceptibility to CC-chemokines among HIV-1 isolates
8. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine cycT1 protein
9. Tat as a transcriptional activator and a potential therapeutic target for HIV-1
10. Coexpression of NF-kappa B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia
11. Hostile takeovers: Viral appropriation of the NF-κB pathway
12. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G
13. Taking a new TAK on tat transactivation
14. Tackling Tat
15. HIV-1 tat transcriptional activity is regulated by acetylation
16. Heterogeneity of HIV-1 and HIV-2
17. Inducible expression of Ikap-paBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells
18. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter
19. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria
20. Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter
21. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes
22. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II
23. Activators and target genes of Rel/NF-kappaB transcription factors
24. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain
25. Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism
26. Recombination in AIDS viruses
27. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV
28. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B′) recombinant strain in China
29. Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon
30. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses
31. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site
32. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
33. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function
34. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk